Scar Treatment Market

Global Market Study on Scar Treatment: Rising Prevalence of Atrophic Scars Complementing Market Growth

Scar Treatment Market Segmented By Post-surgical scars, Acne scars, Contracture scars, Stretch marks, Keloid scars, Hypertrophic scars with Creams, Oil, Gel, Elastic wraps, Sprays Product with Laser Treatment, Chemical Peeling, Invasive surgical treatments, Cryosurgery, Tissue fillers, Steroid Injections Treatment.

  • May-2021
  • PMRREP3471
  • 274 Pages
  • Healthcare

Key Questions Answered in Report

  • What is the expected growth rate for the scar treatment market through 2031?

    By value, Persistence Market Research has projected around 3.4% CAGR for scar treatment during 2021-2031. In terms of revenue, the market is expected to surge from US$ 12 Bn in 2021 to US$ 16.7 Bn in 2031.

  • Which are the most lucrative markets for scar treatment products manufacturers?

    As per Persistence Market Research’s projections, the U.S., Canada, Germany and U.K. are expected to hold the highest share in the market. Together, North America and Europe are projected to hold more than 50% market share through 2031.

  • Who are the prominent scar treatment product manufacturers?

    Top suppliers of scar treatment products include tier-1 companies such as Smith & Nephew, Reckitt Benckiser, B.Braun and ConvaTec, who together accounted for around 50% share of global revenue in 2020.

Find Out More about the Report Coverage


  • Smith and Nephew plc.
  • HRA Pharma
  • Sonoma Pharmaceuticals, Inc.
  • CCA Industries Inc.
  • Cynosure, Inc.
  • Avita Medical Limited
  • Mölnlycke Health Care AB
  • Pacific World Corporation

Report Also Addresses:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand Share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Scar Treatment and How to Navigate
  • Recommendation on Key Winning Strategies

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Sales of Scar Treatment from 2016 to 2020 Vs Market Projections for 2021 to 2031

Historically, from 2016 to 2020, the use of scar treatment and related products increased at around 2.7% CAGR, wherein, developed countries such as the U.S., Canada, Germany, and the U.K. held a significant share of the global market.

Rising concerns among individuals regarding their aesthetic appearance is a major factor boosting interest in scar treatment products. Serious scars or marks caused due to of road accidents is also adding to market development.

According to the information published by WHO, almost 10 million individuals are injured due to road accidents each year. Topical products mostly reduce these scars. Road accidents additionally lead to rise in demand for medical procedures, which further drives interest in laser instruments. Increasing cases of burn injuries is also a factor boosting demand for scar removal treatment.

Rising occurrences of skin diseases together with increasing customer awareness regarding different scar treatment options represent major factors boosting development of the market. Considering these statistics and shift in dynamics, the market for scar treatment is forecast to expand at a healthy CAGR of around 3.4% over the coming 10 years.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

What are the Key Opportunities for Scar Treatment Product Manufacturers?

High occurrence of skin diseases is the main factor boosting market development around the world. Skin diseases such as photoaging, eczema, and vitiligo are rising because of excessive exposure to ultraviolet (UV) radiation and pollution, which leads to hair loss, sunburn, and reduced skin elasticity. These conditions, without appropriate management and treatment on time, can result in the development of scars. To treat such skin diseases and overcome the harmful impacts of UV radiation, scar treatment products are highly utilized.

Other factors such as rise in affluent population, increasing urbanization, growing disposable income, introduction of natural and organic products, and aggressive promotional strategies by service providers are expected to boost the market over the forecast period.

Scar Treatment Market

Explore Persistence Market Research’s expertise in promulgation of the business !

Country-wise Analysis

What Makes the U.S. the Largest Market for Scar Treatment?

The market size of the U.S. is estimated to be US$ 4.4 Bn in 2021 due to increase in the number of road accidents in the last few years. At present, it holds the maximum share of the global market, and it is relied upon to follow a similar trend during the forecast years.

As indicated by the Highway Loss Data Institute (HLDI) and Insurance Institute for Highway Safety (IIHS), there were 34,247 vehicle crashes in the United States in 2017, in which around 37,133 fatalities were recorded.

Another factor supporting market growth in the country include high disposable income, which is leading to more spending on personal care products. Also, rising appearance awareness among the people in the country has prompted increased utilization of cutting-edge scar treatment products.

Why is Demand for Scar Treatment Products Flourishing in the U.K.?

The U.K. market was valued at US$ 724.6 Mn in 2020, and is expected to experience lucrative growth during the forecast period. The U.K. is a significant part of the European market.

As indicated by BAPRAS (British Association of Plastic, Reconstructive and Aesthetic Surgeons), interest in aesthetic plastic medical procedures and scar therapy is rising because of increasing number of NHS plastic medical procedure centres and units in the country. Besides, plastic medical procedures for reconstructive reasons is free of cost under the National Health Services (NHS).

Also, rising skin problems due to increasing UV radiation and pollution, which gives rise to skin problems and burns, is aiding market development. In addition, technological advancements is also a major factor leading to market growth in the country.

What Factors are Leading to Development of India’s Scar Treatment Market?

The market in India is expected to experience lucrative growth and expand at a CAGR of around 4.7%. Major factor driving the market is rising prevalence of burn cases; around 7 million burn injuries in India each year.

Around 4 out of 5 people burnt are children and women in India, which is expected to boost the market growth. Moreover, electrical burns occur in large numbers in India, mostly farmers, which is an important factor driving demand for scar treatment in the country.

Why is China a Lucrative Market for Scar Treatment Device Manufacturers?

The market in China is estimated to be valued at US$ 1.9 Bn in 2021, and expand at a healthy CAGR of 5.3% over the next ten years. Major market players are focusing on technological advancements in their products and R&D to introduce new products into the market.

Moreover, rising occurrences of burn cases are anticipated to drive growth of the market during the forecast period. For example, in February 2019, the Journal of Experimental and Therapeutic Medicine reported that 13,205 burn patients were hospitalized at the Army Medical University Hospital of the Burn Research Institute of Southwest, China between 2009- 2016.

Category-wise Insights

Why is Demand for Topical Scar Products Continuously Rising?

Based on product, topical scar products are leading the market and are expected to gain more than 55% of the revenue share over the forecast period. As silicone sheets, topical gels, and creams are usually obtained as over-the-counter (OTC) products, besides being cost-effective, it enhances their utilization for the treatment for scars.

Why is Prevalence of Atrophic Scars High?

The atrophic scars segment represented the largest market and accounted for a revenue of US$ 8.3 billion in 2020, and the segment is expected to expand at a CAGR of 3.6% through 2031.

Different factors are responsible for developing atrophic scars in the skin, such as surgeries, exposure to inflammatory conditions for a long period, accidents, or other genetic factors. Primary treatments at first are moisturizers, soaps, and gentle cleansing agents, which are not on the skin, yet eliminate oil, bacteria, and dirt from the skin.

Why Do Hospitals Enjoy a High Share for Scar Treatment?

The hospital's segment is expected to contribute maximum revenue share in the global market; 37.2% share in 2021.

Development in clinical approaches in various countries such as the U.S. are ongoing Likewise, Japan has achieved enhanced cost-effectiveness viability for various diagnostic administrations and treatments, which has consequently led to more people opting for these treatments at hospitals.

What is the Impact of Market Consolidation on This Space?

As there is consolidation in the market, major players are concentrating on acquisitions and mergers to explore lucrative opportunities in this space. Leading players are additionally concentrating on enhancing their commercializing efforts by following administrative guidelines.

For instance, in December 2019, Janssen Biotech, Inc. entered a definitive agreement to acquire all rights to the investigational compound bermekimab, an anti-IL-1alpha monoclonal antibody for the treatment of atopic dermatitis and hidradenitis suppurativa, from XBiotech Inc.

What is the Impact of COVID-19 on Demand for Scar Treatment?

The COVID-19 pandemic has affected nearly all businesses worldwide, including the market for scar treatment. Medicine shortages due to supply disruptions were seen across several nations, basically because of temporary lockdowns of manufacturing facilities, export bans, and high focus on the treatment of COVID-19.

Interest in scar treatment products witnessed a decline, resulting in a decrease in market growth rate. However, demand for these products observed remarkable increase from the last quarter of 2020, after operations at manufacturing plants resumed with the end of lockdowns, resumption of skin care facilities, and restarting of exports and imports of these products.

Competitive Landscape

Persistence Market Research has profiled the following key scar treatment product manufacturers in its report:

  • Smith & Nephew plc.
  • HRA Pharma
  • Sonoma Pharmaceuticals, Inc.
  • CCA Industries Inc.
  • Cynosure, Inc.
  • Avita Medical Limited
  • Mölnlycke Health Care AB
  • Pacific World Corporation
  • Shanghai Fosun Pharmaceuticals Ltd.
  • Beijing Toplaser Technology Company Limited
  • Bausch Health Companies Inc.

Manufacturers are focusing on expansion of their product portfolios by launching new, technologically advanced products and by receiving approval from different government bodies.

  • In June 2020, Bausch Health Companies Inc., under its dermatology business, launched ARAZLO (tazarotene) lotion (0.045%), which is available commercially for healthcare professionals in the U.S. The product was approved by USFDA in December 2019. The lotion helps patients treat multiple forms of acne, which include blackheads, whiteheads, and pimples.
  • In July 2019, Dermatix, a brand ofA. Menarini Singapore Pte. Ltd., launched Dermatix Acne Scar cream, which repairs acne scars through exfoliation. It comprises vitamin B3, alpha hydroxy acids (AHAs), and antioxidants, which target specific acne aftereffects, including scars and dark spots.

Similarly, recent developments related to companies manufacturing scar treatment products have been tracked by the team at Persistence Market Research, which is available in the full report.

Scope of Report                  



Forecast Period


Historical Data Available for


Market Analysis

USD Million for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Key Countries Covered

  • US
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Australia
  • New Zealand
  • South Africa
  • GCC Countries

Key Segments Covered

  • Product
  • Application
  • End User
  • Region

Key Companies Profiled

  • Smith & Nephew plc.
  • HRA Pharma
  • Sonoma Pharmaceuticals, Inc.
  • CCA Industries Inc.
  • Cynosure, Inc.
  • Avita Medical Limited
  • Mölnlycke Health Care AB
  • Pacific World Corporation
  • Shanghai Fosun Pharmaceuticals Ltd.
  • Beijing Toplaser Technology Company Limited
  • Bausch Health Companies Inc.

Report Coverage

  • Market Forecasts
  • Company Share Analysis
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Market Segments Covered


  • Topical Scar Treatment Products
    • Scar Treatment Gels
    • Scar Treatment Creams
    • Scar Treatment Oils
    • Scar Treatment Sheets
  • Scar Treatment Lasers
    • CO2 Lasers
    • Excimer Lasers
    • Pulsed Dye Lasers
  • Surface Scar Treatment
  • Injectable Scar Treatment


  • Atrophic Scar Treatment
    • Acnes
      • Ice Picks
      • Box Scars
      • Rolling Acnes
    • Trauma and Surgery
  • Hypertrophic Scars and Keloids
  • Contracture Scar Treatment
  • Stretch Marks


  • Scar Treatment at Hospitals
  • Scar Treatment at Clinics
  • Scar Treatment Products Sold at Pharmacies & Drug Stores
  • Scar Treatment Products Sold through e-Commerce


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa


Antiseptic Bathing Market

According to a latest research by the company, the global antiseptic bathing market is anticipated to account for over US$ 549.3 Mn in terms of value, by 2026 end..

Facial Bone Contouring Market

Global facial bone contouring market, for a timeline of eight years, 2018-2026.

Stromal Vascular Fraction Market

The global market CAGR estimated for the assessment period 2017-2025 is 4.2%. The market for stromal vascular fraction is currently in its nascent stage, and awaits the establishment of the safety and efficacy of SVF devices..

Autologous Conditioned Plasma Market

PMR’s market research is based on autologous conditioned plasma therapy market offers information divided into 5 important segments - composition, source, indication, end user & region.

Our Clients

Our Clients